Testing DragonFire for obstructive hypertrophic cardiomyopathy
Part of Heart & circulation clinical trials.
This study tests a new procedure called DragonFire that uses a thin tube and radiofrequency energy to reduce heart muscle thickening and improve blood flow in people with a specific type of heart muscle disease (obstructive hypertrophic cardiomyopathy). It is an option for patients who still have symptoms despite medication and are not good candidates for open-heart surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have a type of heart muscle thickening (obstructive hypertrophic cardiomyopathy) that causes a blockage, and your doctor has measured a pressure gradient of at least 50 mmHg across your heart valve.
- You have significant symptoms like fatigue, shortness of breath, chest pain, or fainting, and standard medicines haven't worked well or have caused side effects.
- Your heart failure limits your daily activities (NYHA class II with certain complications, or class III/IV), and you are considered high-risk for open-heart surgery or you have chosen to avoid surgery after learning about the risks.
- You are expected to live more than 12 months and can follow the study schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial combines a new heart medication (mavacamten) with a procedure called radiofrequency ablation to treat a condition where the heart muscle thickens and blocks blood flow. It is for people who still have symptoms despite standard care.
This trial tests a new treatment that uses radiofrequency energy (similar to heat) to shrink the thickened heart muscle blocking blood flow. It is for people with obstructive hypertrophic cardiomyopathy who have symptoms despite medication and are not able or willing to have heart surgery.
This trial tests a catheter-based procedure (putting a small device through blood vessels) to repair a leaking mitral valve caused by heart muscle problems. It aims to reduce symptoms and improve heart function and safety in people who are still having heart failure symptoms despite standard treatment.
This trial tests the safety and effectiveness of a heart procedure that repairs a leaking mitral valve through thin tubes, using the Dragonfly system. It’s for people who have significant mitral valve leak symptoms but are considered high risk for open-heart surgery.
This trial tests a device called the Dragonfly system to fix a leaky mitral valve caused by heart muscle problems. It may help people with symptoms like shortness of breath or fatigue from this condition.
This trial looks at how the heart's electrical signals work in people with hypertrophic cardiomyopathy (a condition where the heart muscle becomes thickened) who also have atrial fibrillation (a type of irregular heartbeat). The goal is to understand these signals better during a planned ablation procedure, which is a treatment to fix the irregular rhythm.
Hear when a new Obstructive Hypertrophic Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.